News
ReNeuron's latest press releases
ReNeuron secures £2.5 million financing . 24/06/08
Guildford, UK, 24 June 2008: ReNeuron Group plc (LSE: RENE.L) today announces that it has secured £2.5 million of further financing from its …
Read articleNotification of Preliminary Results. 20/06/08
Guildford, UK, 19 June 2008:ReNeuron Group plc (LSE: RENE.L) today announces that it will report its preliminary results for the year ending 31 March …
ReNeuron to present at leading US stem cell conference. 11/06/08
Guildford, UK, 11 June 2008: ReNeuron Group plc (LSE: RENE.L) today announces that it will be presenting at the 6th Annual Meeting of the …
ReNeuron signs contract with Angel Biotechnology to manufacture ReN001 stem cells for UK clinical trials in stroke. 29/05/08
Guildford, UK, 29 May 2008: ReNeuron Group plc (LSE: RENE.L) today announces that it has signed a new manufacturing contract with Angel Biotechnology …
ReNeuron welcomes UK Government vote on Embryology Bill . 21/05/08
Guildford, UK, 20 May 2008: ReNeuron Group plc (LSE: RENE.L) today welcomes Parliament's decision to approve research on stem cells derived from human-…
ReNeuron receives notice of US patent grant covering generation of islet cells for ReN002 diabetes programme. 21/05/08
Guildford, UK, 21 May 2008: ReNeuron Group plc (LSE: RENE.L) today announced that it has received a notification of grant from the US Patent and …
ReNeuron announces further pre-clinical data with its ReN003 programme for diseases of the retina . 23/04/08
Guildford, UK, 23 April 2008: ReNeuron Group plc (LSE:RENE.L) today announces further pre-clinical data regarding its ReN003 stem cell therapy …
Regulatory update . 19/03/08
Guildford, UK, 19 March 2008: ReNeuron Group plc (LSE: RENE.L) today provides a further update on progress with its regulatory strategy for its ReN001 …
1 2 3 4 5 6 7 8 9 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page